A soft robot could perform real-time imaging, deliver drugs, and take biopsies within the hard-to-reach small intestine.
Measuring cell-free DNA in blood could help oncologists assess how well CAR T-cell therapy is working for treatment of blood ...
A new AI system from Mayo Clinic finds signs of the most common form of pancreatic cancer much earlier than standard ...
A circular RNA (circRNA) drug enhanced saliva production in radiation-induced xerostomia, a promising development in the ...
Genetic differences impact immune cells and may pave the way to new precision medicines for conditions as diverse as multiple ...
Phase III findings suggest a promising option for women whose endometrial cancer progresses despite prior chemotherapy and ...
NeoCOAST-2 trial finds early ctDNA clearance in blood tests linked to improved lung cancer outcomes, potentially guiding ...
UBT251, the triple hormone-receptor agonist developed by United Biotechnology and licensed by Novo Nordisk for treatment of type 2 diabetes and obesity, has achieved good blood sugar-lowering and ...
A blood test could help clinicians identify patients with traumatic brain injury (TBI) who may otherwise go undiagnosed.
Researchers have developed an AI-powered personal health agent created as an open-source multi-agent framework for dynamic, personalized health interactions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results